THE ROLE OF THE NATIONAL REGISTRY IN PROVIDING LONG-TERM CARE FOR PATIENTS WITH RARE DISEASES
Journal Title: Българско списание за обществено здраве (Bulgarian Journal of Public Health) - Year 2018, Vol 0, Issue 3
Abstract
Rare diseases have become a policy priority in the common European public health. Limited number of patients and scarcity of knowledge and expertise – designate them as a distinctive domain of very high added-value for action at the community level in this area. The establishment of registers for patients with rare diseases is a priority in the European Union and the European Commission has taken active steps to support their development. Since May 2017 the National Registry for Patients with Rare Diseases has been functioning at national level as a monitoring system to collect epidemiological data on rare diseases in the country, support for policy development and healthcare planning.
Authors and Affiliations
Reni Petkova, Petko Salchev, Plamen Dimitrov
CLIMATE CHANGE IN EUROPE AND THREATS OF MYCOTOXINS
Climate changes may have an impact on the occurrence of food safety hazards at various stages of the food chain, from primary production to consumption. Climate related factors include: changes in temperature and precipi...
COMPARATIVE EVALUATION OF CLINICAL EFFICIENCY AND COST-EFFECTIVENESS OF TARGETED CANCER THERAPY
The high prices of the targeted TKI therapies cause fierce debates in Bulgaria and in economically developed countries. All questions about the cost-effectiveness of TKI therapies motivate a number of researchers to exam...
REGISTERS IN THE BULGARIAN HEALTHCARE SYSTEM: CURRENT STATUS
The role of health registers is to be used for information, analyses and strategic planning purposes. In the countries with well-regulated healthcare the information about diseases, especially major ones, is as accurate...
STRESS AND HEALTH MANAGEMENT AT THE WORKPLACE – PERSPECTIVES OF THE SOLVE METHODOLOGY
The aim of the article is to present a comprehensive results review of the main activities of the national facilitator of ILO’s SOLVE methodology covering his 10 years history. To announce the main directions and volumes...
FIRST STUDIES ON THE BULGARIAN MARKET FOR BISPHENOL A IN INFANT FEEDING BOTTLES
Bisphenol A (BPA) is an organic compound used primarily as a monomer in production of polycarbonate plastics, epoxy resins and as a non-polymer additive to other plastics. Because of the extensive use of BPA in the manuf...